Pao2 levels. Since both the incidence and the severity of RLF are directly related to the degree of prematurity as manifested by low birthweight (see Tables  1, 2) , this disorder can be expected to become an even more serious problem with the increasing capability of preserving life in extremely small premature infants.
In the majority of infants with RLF there is a spontaneous regression of the active stages with a subsequent normal vision. It has been found, however, that about 5% will become totally blind due to cicatricial RLF (Table 2 ). In addition, a certain number, as yet undetermined, will show other serious ocular abnormalities such as high myopia, vitreous traction, dragged retinal vessels, heterotopic macula, strabismus, and amblyopia. Late complications include peripheral retinal degeneration, retinoschisis, retinal tears, and retinal detachment.
Several authors1-3 have worked out grading systems for the classification of the various stages of acute and cicatricial RLF. angiography and the clinicopathological correlations derived from it. There are, however, only a few recent reports on the incidence, prevalence, and natural history of this disease, especially in premature babies with RLF weighing below 1500 g at birth.
Since RLF has characteristics which are common to other ischaemic retinopathies, it was only natural that methods of treating such retinopathies, such as photocoagulation and cryopexy, would be tried in its treatment as well. Conflicting results have been obtained by this approach,5-'2 probably owing to the lack of clear indications as to the optimal time of treatment and the exact method to be used.
In July 1976 a prospective study was started on premature babies with acute RLF to see whether blindness could be prevented by giving cryopexy treatment to selected eyes judged to have an increased probability of developing severe cicatricial RLF. The results of Kingham's Among the 55 infants with active RLF the retinopathy never exceeded stage II in 46 (84%), and eventually spontaneously regressed and healed. All the 9 infants in whom the active retinopathy started to progress beyond stage II and who were subjected to treatment weighed below 1500 g at birth. Three weighed between 1001 and 1500 and 6 weighed between 500 and 1000 g (Table 3 ). In these infants the temporal ridge was thick, and the neovascular Treatment of acute retrolental fibroplasia by cryopexy Among the 533 premature infants studied by us there was an inverse relationship between the birth weight of the infant and the prevalence of acute RLF (see Table 4 ). It is of note that in the group of premature babies with a birth weight under 1000 g the prevalence of acute RLF was between 61 and 75% (Table 1) , and generally the RLF changes were more advanced than in premature babies with RLF with birth weight above 1000 g.
Few statistics have been reported on the results of cryopexy treatment. In the co-operative 5-year study on the natural history of RLF,14 which involved 5 central intensive neonatal care units, there were 66 infants with acute RLF, of whom 32 were between 1000 and 1200 g birth weight. Of these, 3 became blind due to grades IV and V cicatricial RLF, and 3 had grade III cicatricial RLF, both stages being compatible either with low v4sion or with legal blindness. Of the 35 premature babies weighing 500-1000 g at birth who were followed up at the Montreal Children's Hospital by Gunn et al.15 15 (43%) had cicatricial RLF; of these, 6 (20%) children were blind, 10 other children (28%) had high myopia, and 2 more had esotropia.
Since our findings, as well as those of other workers, indicate that the prevalence and severity of RLF are positively related to the degree of retinal prematurity, or in other words to the extent of the zone of avascular hypoxic retinal tissue, it may be assumed that the development of RLF is triggered, as are other ischaemic retinopathies, by a vasoformative substance produced in the ischaemic retina. The larger the stimulus in the area of the available ischaemic retina to produce this substance, the greater would be the vasoproliferation, and hence the greater would be the chance for occurrence of complications leading to cicatricial forms. As in other ischaemic retinopathies, destruction of ischaemic retina is believed to reduce the formation of vasoformative substance and consequently to cause an arrest of the disease.
Our results suggest that such a destruction is easily achieved with cryopexy. In each of the treated eyes there was a rapid resolution or regression of the acute RLF changes. We decided to treat the second eye when it was observed that during the 2-6 weeks of the follow-up period the untreated eye continued to deteriorate, while the previously treated eye showed good regression of the acute RLF.
No complications were encountered which could be attributed to the cryopexy. These findings are unlike those of Kingham,'2 who, in an unrandomised treatment study, reported optic atrophy and severe forms of cicatricial retinopathy after cryoapplication. These different results may be attributed to the differences in the time of treatment, to the surgical technique, and to the location of the cryoapplications. In our mode of treatment we did not attempt to destroy directly the ridge or the neovascular fronds themselves, but applied the cryoprobe only to the avascular peripheral retina, an approach which did not necessitate incising the conjunctiva, pulling muscles, and applying an inevitably stronger pressure on the premature eye. Since we treated the peripheral avascular retina while it was still close to the choroid and not already highly detached, we were able to freeze it properly and by less extensive applications. When the retina is already highly detached, heavy cryoapplication over the sclera and choroid may increase leakage from the choroidal vessels and thus increase the exudative detachment.
In Kingham's report12 from a series of 101 premature babies of various birth weights, of whom 14 eyes were treated, there was 7% of blindness. We feel that if treatment is performed earlier the rate of blindness should be less, because the acute RLF does not progress to stage IV, a stage in which the chance of successful treatment is, as previously explained, smaller. For the later stages of active, as well as for cicatricial RLF, surgery with an external buckling procedure may be the best solution. '6 In light of the above findings it is encouraging to report that in our preliminary treatment study there was not a single case of blindness among the 55 children with acute RLF, of whom 32 had a birth weight below 1000 g, and none progressed beyond active stage III. These results indicate that cryotherapy used in the method described here is safe and effective in arresting acute RLF and in preventing the progress of the retinopathy towards the severe forms of active and hence cicatricial RLF. The question which remains open is which of the treated children would have had their disease spontaneously regress if left untreated. Since all the children were treated before they reached active stage IV, unlike those in Kingham's series, it is impossible to provide an answer to this question until better criteria for prediction are available.
